ArticleBiomaterials research2026
Amphiphilic Lipid-Single-Stranded DNA Conjugate-Mediated Cell Surface Engineering for Programmable Intercellular Tethering and Immune Synapse Formation.
Article in Biomaterials research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intercellular tethering and interface stability critically influence cellular activation, particularly in solid tumors where physical constraints limit sustained effector-target engagement. In particular, effective immune-synapse formation in natural killer cells requires stable cell-cell contact. However, most existing strategies rely on tumor-antigen-mediated recognition and are therefore vulnerable to antigen heterogeneity and immune escape. Here, we developed an amphiphilic single-stranded DNA (ssDNA)-based surface-engineering strategy that enables controllable and receptor-independent regulation of intercellular interfaces. Lipid-conjugated ssDNA constructs were designed to (a) anchor onto cell membranes, (b) induce sequence-specific association through DNA hybridization, and (c) enable thermally reversible dissociation of tethered cell pairs. This membrane modification was rapidly achieved, and complementary ssDNA pairing markedly increased effector-target tethering, cytotoxic granule and cytokine secretion, and elimination of triple-negative breast cancer cells. Importantly, this platform remained effective in 3-dimensional tumoroid models, where amphiphilic ssDNA enabled robust membrane localization and facilitated natural-killer-cell-mediated tumor disruption. Collectively, these results demonstrate that immune-synapse efficiency could be actively modulated by engineering the physical properties of intercellular interfaces. Moreover, this programmable ssDNA-based platform offers a versatile framework for regulating diverse cell-cell interfaces, with broad applicability across immunotherapy, tissue engineering, and cell-based therapeutic systems.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.